Characterization of Neuropeptide Y (NPY) Receptors

互联网2013-12-31

1530

Abstract
Table of Contents
Materials
Figures
Literature Cited

Abstract

Neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) constitute a trio of structurally related peptides that elicit a variety of physiological responses in targets including the brain, gut, and vascular smooth muscle. These actions are mediated by a family of G protein?coupled receptors, each of which exhibits a distinct pharmacological fingerprint. This unit describes protocols for identifying and characterizing the pharmacological properties of two NPY receptor subtypes, Y₁ and Y₂ . At least four other members of this receptor family have been described (Y₃ , Y₄ , Y₅ and y6), and a brief description of these receptors and relevant literature citations are also provided.

GO TO THE FULL PROTOCOL:

PDF or HTML at Wiley Online Library

Basic Protocol 1: Competition Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Rat Brain Tissues
Alternate Protocol 1: Saturation Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Rat Brain Tissues
Basic Protocol 2: Competition Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Human Neuroblastoma Cell Lines
Alternate Protocol 2: Saturation Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Human Neuroblastoma Cell Lines
Reagents and Solutions
Commentary
Literature Cited
Figures
Tables

GO TO THE FULL PROTOCOL:

PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Competition Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Rat Brain Tissues

Materials

Frozen rat cerebral cortex (Y₁ ) or hippocampus (Y₂ ), dissected fresh and immediately frozen, or purchased frozen from a commercial vendor (e.g., Pel‐Freez)
Homogenization buffer (see recipe ), ice cold
Tissue binding buffer (see recipe ), ice cold
Competing ligands: unlabeled peptide YY (PYY), reference peptides (e.g., Bachem California or Peninsula Labs; see Table 1.11.2 ), or other test compounds
25 nM [¹²⁵ I]PYY (Amersham; ∼2200 Ci/mmol; store aliquots at −20°C)
50 mM HEPES buffer, pH 7.4, ice cold

Motor‐driven, glass‐fitted Teflon homogenizer, chilled
High‐speed refrigerated centrifuge (e.g., Beckman model J2‐MI)
Motorized tissue homogenizer (e.g., Brinkmann Polytron)
12 × 75–mm polypropylene tubes
Whatman GF/C filters
0.1% (w/v) polyethyleneimine (PEI)
Brandel 48‐sample cell harvesting unit

NOTE: Buffers should be kept cold. Always keep tissue homogenates and pellets on ice.

Table 1.1.2 MaterialsPharmacological Characterization of [¹²⁵ I]PYY‐Labeled Y₁ and Y₂ Receptors in Rat Brain Membranes

Compound e	K _i (nM)
Y₁ (cortex) f	Y₂ (cortex) g	Y₂ (hippocampus)
hNPY	2.0	2.0	4.0
pNPY	1.0	2.0	3.0
hPYY	2.0	0.5	1.0
p[Leu³¹ Pro³⁴ ]NPY	2.0	>300	>300
h[Leu³¹ Pro³⁴ ]PYY	1.0	>300	>300
pNPY_2‐36	20	2.0	4.0
hNPY_3‐36	200	3.0	2.0
hPYY_3‐36	280	0.5	2.0
pNPY_13‐36	>300	10	15
hPP	>300	>300	>300
BIBP 3226	8.0	>300	>300

^e h, human; p, porcine. Peptides can be purchased from Bachem California or Peninsula Labs. BIBP 3226 can be obtained from Research Biochemicals.

^f Assayed in the presence of 200 nM unlabeled pNPY_13‐36 .

^g Assayed in the presence of 100 nM unlabeled p[Leu³¹ Pro³⁴ ]NPY.

Alternate Protocol 1: Saturation Analysis to Determine Y1 and Y2 Receptor Number and Affinity in Rat Brain Tissues

Materials

Human neuroblastoma cell lines: SK‐N‐MC (American Type Culture Collection, ATCC, no. HTB 10), SK‐N‐BE2 (W. Karbon), or KAN‐TS (Amersham Research Biochemicals)
Growth medium (see recipe )
Competing ligands: unlabeled peptide YY (PYY), reference peptides (e.g., Bachem California or Peninsula Labs; see Table 1.11.3 ), or other test compounds
Cell binding buffer (see recipe )
25 nM [¹²⁵ I]PYY (Amersham; ∼2200 Ci/mmol; store aliquots at −20°C)
Eagle's minimal essential medium (EMEM; Life Technologies), ice cold
1 N NaOH

Humidified 95% O₂ /5% CO₂ incubator
Fibronectin‐coated 24‐well tissue culture plates (Becton Dickinson Labware)
12 × 75–mm polypropylene tubes

Additional reagents and equipment for counting cells (Phelan, )

Table 1.1.3 MaterialsPharmacological Characterization of [¹²⁵ I]PYY‐Labeled Y₁ and Y₂ Receptors in Human Neuroblastoma Cells

Compound h	K _i (nM)
Y₁ (SK‐N‐MC)	Y₂ (SK‐N‐BE2)
hNPY	3.0	3.0
hPYY	2.0	1.0
p[Leu³¹ Pro³⁴ ]NPY	3.0	220
h[Leu³¹ Pro³⁴ ]PYY	5.0	250
pNPY_2‐36	22	5.0
hNPY_3‐36	110	5.0
hPYY_3‐36	80	1.0
pNPY_13‐36	300	3.0
hPP	>300	>300
BIBP 3226	10	>300

^h h, human; p, porcine. Peptides can be purchased from Bachem California or Peninsula Labs. BIBP 3226 can be obtained from Research Biochemicals.

GO TO THE FULL PROTOCOL:

PDF or HTML at Wiley Online Library

Figures

Figure 1.11.1 Specific [¹²⁵ I]PYY binding to Y₁ (A) and Y₂ (B ) receptor subtypes in rat brain cerebral cortical membranes, and (C ) to Y₂ receptors in hippocampal membranes. The binding assay was performed as described in the text (see ). Each point represents the mean of at least three independent determinations.

View Image

Videos

Literature Cited

Literature Cited
	Bard, J., Walker, M.W., Branchek, T.A., and Weinshank, R.L. 1995. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J. Biol. Chem. 270:26762‐26765.
	Blomquist, A.G. and Herzog, H. 1997. Y‐receptor subtypes–How many more? Trends Pharmacol. Sci. 20:294‐298.
	Dumont, Y., Fournier, A., St.‐Pierre, S., and Quirion, R. 1995. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3‐36 as selective Y1 and Y2 radioligands. J. Pharmacol. Exper. Ther. 272:673‐680.
	Fuhlendorff, J., Gether, U., Aakerlund, L., Langeland‐Johansen, N., Thogersen, H., Melberg, S.G., Olsen, U.B., Thastrup, O., and Schwartz, T.W. 1990. [Leu31,Pro34]Neuropeptide Y—A specific Y1 receptor agonist. Proc. Natl. Acad. Sci. U.S.A. 187:182‐186.
	Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl‐Hartmann, C., Smith, K.E., Vaysse, P., Durkin, M.M., Laz, T.M., Linemeyer, D.L., Schaffhauser, A.O., Whitebread, S., Hofbauer, K.G., Taber, R.I., Branchek, T.A., and Weinshank, R.L. 1996. A receptor subtype involved in neuropeptide Y‐induced food intake. Nature 382:168‐171.
	Gregor, P., Feng, Y., DeCarr, L.B., Cornfield, L.J., and McCaleb, M.L. 1996. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J. Biol. Chem. 271:27776‐27781.
	Hu, Y., Bloomquist, B.T., Cornfield, L.J., DeCarr, L.B., Flores‐Riveros, J.R., Friedman, L., Jiang, P., Lewis‐Higgins, L., Sadlowski, Y., Schaefer, J., Velazquez, N., and McCaleb, M.L. 1996. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 42:26315‐26319.
	Krause, J., Eva, C., Seeburg, P.H., and Sprengel, R. 1992. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor J. Mol. Pharmacol. 41:817‐821.
	Matsumoto, M., Nomura, T., Momose, K., Ikeda, Y., Kondou, Y., Akiho, H., Togami, J., Kimura, Y., Okada, M., and Yamaguchi, T. 1996. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 271:27217‐27220.
	Michel, M.C. 1991. Receptors for neuropeptide Y: Multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12:3789‐3794.
	Phelan, M.C. 1998. Techniques for mammalian cell tissue culture. In Current Protocols in Molecular Biology (F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds.) pp. A.3F.1‐A.3F.14. John Wiley & Sons, New York.
	Rose, P.M., Fernandes, P., Lynch, J.S., Frazier, S.T., Fisher, S.M., Kodukula, K., Kienzle, B., and Seethala, R. 1995. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 29:22661‐22664.
	Wahlestedt, C., Yanaihara, N., and Håkanson, R. 1986. Evidence for different pre‐ and postjunctional receptors for NPY and related peptides. Regul. Pept. 13:307‐318.
	Wahlestedt, C., Edvinsson, L., Ekblad, E., and Håkanson, R. 1987. Effects of neuropeptide Y at sympathetic neuroeffector junctions: Evidence of Y1 and Y2 receptors. In Neuronal Messengers in Vascular Function (A. Nobin, C. Owman, and B. Arneklo‐Nobin, eds.) pp. 231‐241. Elsevier/North‐Holland, Amsterdam.
	Wahlestedt, C., Regunathan, S., and Reis, D.J. 1991. Identification of cultured cells selectively expressing Y1‐, Y2‐, or Y3‐type receptors for neuropeptide Y/peptide YY. Life Sci. 50:PL‐7–PL‐12.
	Wan, C.P. and Lau, B.H.S. 1995. Neuropeptide Y receptor subtypes. Life Sci. 56:1055‐1064.
	Weinberg, D.H., Sirinathsinghji, D.J.S., Tan, C.P., Shiao, L.‐L., Morin, N., Rigby, M.R., Heavens, R.H., Rapoport, D.R., Bayne, M.L., Cascieri, M.A., Strader, C.D., Linemeyer, D.L., and MacNeil, D.J. 1996. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271:16435‐16438.
	Yan, H., Yang, J., Marasco, J., Yamaguchi, K., Brenner, S., Collins, F., and Karbon, W. 1996. Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. Proc. Natl. Acad. Sci. U.S.A. 93:4661‐4665.